[{"address1": "Royal Bank Plaza", "address2": "Suite 2800 South Tower 200 Bay Street", "city": "Toronto", "state": "ON", "zip": "M5J 2J1", "country": "Canada", "website": "https://satellos.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Satellos Bioscience Inc., a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia. The company uses its proprietary platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247 an oral, small-molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a license agreement the with Ottawa Hospital Research Institute (OHRI); and an option agreement with the University of British Columbia. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.", "fullTimeEmployees": 14, "companyOfficers": [{"maxAge": 1, "name": "Mr. Francis  Gleeson B.B.A. M.B.A", "age": 70, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1955, "fiscalYear": 2024, "totalPay": 553920, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Elizabeth  Williams C.A., CPA", "age": 47, "title": "CFO & Corporate Secretary", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 387744, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philip  Lambert M.A., Ph.D.", "age": 57, "title": "Chief Scientific Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 559519, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael A. Rudnicki Ph.D.", "age": 64, "title": "Co-Founder & Chief Discovery Officer", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 88627, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. J. Robert Hall CFA", "title": "Senior Vice President of Finance & Administration", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Liggett B.Sc., Bsc. Pharm., C.A., C.P.A.", "age": 65, "title": "Strategic Advisor", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 32853, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Warren  Whitehead C.M.A., CPA", "age": 73, "title": "Head of Corporate Strategy", "yearBorn": 1952, "fiscalYear": 2024, "totalPay": 231568, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Desiree  Chan", "title": "Chief of Staff", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ryan  Mitchell Ph.D.", "title": "Senior Vice President of Medical & Scientific Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Wildon  Farwell M.D., M.P.H.", "age": 50, "title": "Chief Medical Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 11.55, "open": 0.88, "dayLow": 0.88, "dayHigh": 0.939, "regularMarketPreviousClose": 11.55, "regularMarketOpen": 0.88, "regularMarketDayLow": 0.88, "regularMarketDayHigh": 0.939, "payoutRatio": 0.0, "beta": 0.712, "trailingPE": 4.723736, "forwardPE": -55.18182, "volume": 33600, "regularMarketVolume": 33600, "averageVolume": 12127, "averageVolume10days": 19842, "averageDailyVolume10Day": 19842, "bid": 0.901, "ask": 0.939, "bidSize": 1300000, "askSize": 400000, "marketCap": 187671408, "fiftyTwoWeekLow": 0.88, "fiftyTwoWeekHigh": 12.5, "allTimeHigh": 21.8184, "allTimeLow": 0.042, "fiftyDayAverage": 7.3432326, "twoHundredDayAverage": 6.0833826, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 145219648, "profitMargins": 0.0, "floatShares": 13054906, "sharesOutstanding": 15458929, "heldPercentInsiders": 0.08302, "heldPercentInstitutions": 0.082399994, "impliedSharesOutstanding": 15458929, "bookValue": 2.204, "priceToBook": 5.5081673, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -21565172, "trailingEps": 2.57, "forwardEps": -0.22, "lastSplitFactor": "1:12", "lastSplitDate": 1769731200, "enterpriseToEbitda": -6.04, "52WeekChange": 0.90521026, "SandP52WeekChange": 0.11527538, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "MSCLF", "underlyingSymbol": "MSCLF", "shortName": "SATELLOS BIOSCIENCE INC.", "longName": "Satellos Bioscience Inc", "firstTradeDateEpochUtc": 1629293400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "48842655-835e-3cc4-bfca-60f3fe40b54a", "messageBoardId": "finmb_650365067", "gmtOffSetMilliseconds": -18000000, "currentPrice": 12.14, "recommendationKey": "none", "totalCash": 34614000, "totalCashPerShare": 2.239, "ebitda": -24042894, "totalDebt": 0, "quickRatio": 9.94, "currentRatio": 10.704, "returnOnAssets": -0.54254, "returnOnEquity": -0.87594, "grossProfits": -16684621, "freeCashflow": -13990599, "operatingCashflow": -21228352, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2026-02-21"}]